imatinib mesylate has been researched along with Cardiac Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellitti, R; Buonocore, M; Casale, B; Covino, FE; De Rosa, N; Santè, P | 1 |
| Chu, ZB; Guo, T; He, J; Hu, Y; Sun, CY | 1 |
| Fisher, GA; Levitt, L; Lin, AY; So, S; Tang, C | 1 |
1 trial(s) available for imatinib mesylate and Cardiac Cancer
| Article | Year |
|---|---|
Phase II study of imatinib in unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Heart Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Piperazines; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Survival Rate; Treatment Outcome | 2008 |
2 other study(ies) available for imatinib mesylate and Cardiac Cancer
| Article | Year |
|---|---|
Primary cardiac angiosarcoma in a 25-year-old man: excision, adjuvant chemotherapy, and multikinase inhibitor therapy.
Topics: Adult; Antineoplastic Agents; Benzamides; Biopsy; Cardiac Surgical Procedures; Chemotherapy, Adjuvant; Echocardiography, Transesophageal; Heart Neoplasms; Hemangiosarcoma; Humans; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylate.
Topics: Adult; Benzamides; Gene Rearrangement; Heart Neoplasms; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Myeloproliferative Disorders; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2009 |